Will reducing adopogenesis in bone increase bone mass?: PPARgamma2 as a key target in the treatment of age-related bone loss
- 1 January 2003
- journal article
- review article
- Published by Portico in Drug News & Perspectives
- Vol. 16 (6), 341-6
- https://doi.org/10.1358/dnp.2003.16.6.829305